JS
Jayashree Satagopan
About Jayashree Satagopan
Data last updated:
Jayashree Satagopan is a Cfo at Sun Pharmaceutical Industries Limited (since 2025), Cfo at Sun Pharma Laboratories Limited (since 2025) and Director at Ajax Engineering Limited (since 2024). The companies operate in Pharma, Electrical and Manufacturing. The 3 current companies with reported revenue have a combined latest revenue of ₹74,321 Cr; the largest is Sun Pharmaceutical Industries Limited at ₹60,434 Cr (FY 2026). Earlier, Jayashree Satagopan was a Director Appointed In Casual Vacancy at Andhra Paper Limited (2014–2015) and Cfo at Coromandel International Limited (2017–2025) and 7 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sun Pharmaceutical Industries Limited L24230GJ1993PLC019050 | Cfo | 01 Jul 2025 | 1993 | ₹60,434 Cr (FY 2026) | Active |
 Sun Pharma Laboratories Limited U25200GJ1997PLC133846 | Cfo | 01 Jul 2025 | 1997 | ₹12,715 Cr (FY 2024) | Active |
 Ajax Engineering Limited L28245KA1992PLC013306 | Director | 09 Aug 2024 | 1992 | ₹1,173 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Andhra Paper Limited L21010AP1964PLC001008 | Director Appointed In Casual Vacancy | 22 Jul 2014 | 1964 | ₹1,630 Cr (FY 2025) | Active |
 Coromandel International Limited L24120TG1961PLC000892 | Cfo | 01 Nov 2017 | 1961 | ₹31,827 Cr (FY 2026) | Active |
 Pi Industries Limited L24211RJ1946PLC000469 | Cfo | 28 Jul 2015 | 1946 | ₹7,024 Cr (FY 2026) | Active |
 Coromandel Chemicals Limited U20129TS1995PLC175388 | Additional Director | 20 Jul 2018 | 1995 | Active | |
 Dhaksha Unmanned Systems Private Limited U35900TN2019PTC128496 | Nominee Director | 20 Oct 2022 | 2019 | ₹47.51 Cr (FY 2025) | Active |
| Coromandel Technology Limited U35929TG2022PLC169709 | Director | 27 Dec 2022 | 2022 | ₹15.7 Lakh (FY 2024) | Active |
| Dare Ventures Limited U65110TG2012PLC080296 | Additional Director | 25 Jan 2018 | 2012 | ₹1.24 Cr (FY 2025) | Active |
| Coromandel Insurance And Multi Services Limited U66220TS2023PLC178593 | Director | 31 Oct 2023 | 2023 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jayashree Satagopan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jayashree Satagopan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayashree Satagopan
Jayashree Satagopan currently holds 3 directorships: Sun Pharmaceutical Industries Limited (Cfo, since 01 Jul 2025, revenue ₹60,434 Cr (FY 2026)); Sun Pharma Laboratories Limited (Cfo, since 01 Jul 2025, revenue ₹12,715 Cr (FY 2024)); Ajax Engineering Limited (Director, since 09 Aug 2024, revenue ₹1,173 Cr (FY 2023)).
Jayashree Satagopan was first appointed on 22 Jul 2014 as Director Appointed In Casual Vacancy at Andhra Paper Limited. The most recent appointment on record is 01 Jul 2025 at Sun Pharma Laboratories Limited.
The 3 current companies of Jayashree Satagopan that report revenue have a combined latest revenue of ₹74,321 Cr: Sun Pharmaceutical Industries Limited ₹60,434 Cr (FY 2026); Sun Pharma Laboratories Limited ₹12,715 Cr (FY 2024); Ajax Engineering Limited ₹1,173 Cr (FY 2023).
Jayashree Satagopan held 9 earlier board appointments: Andhra Paper Limited (Director Appointed In Casual Vacancy, 22 Jul 2014 to 24 Apr 2015); Coromandel International Limited (Cfo, 01 Nov 2017 to 06 May 2025); Pi Industries Limited (Cfo, 28 Jul 2015 to 20 Oct 2017); Coromandel Chemicals Limited (Additional Director, 20 Jul 2018 to 19 Jul 2019); Dhaksha Unmanned Systems Private Limited (Nominee Director, 20 Oct 2022 to 16 Jun 2025); and 4 more.
The current boards of Jayashree Satagopan's companies include Aalok Dilip Shanghvi (Sun Pharmaceutical Industries Limited), Andreas Eugen Busch (Sun Pharmaceutical Industries Limited), Anoop Anjanikumar Deshpande (Sun Pharmaceutical Industries Limited), Dilip Shantilal Shanghvi (Sun Pharmaceutical Industries Limited), Kirti Wardhaman Ganorkar (Sun Pharmaceutical Industries Limited), Pawan Kumar Goenka (Sun Pharmaceutical Industries Limited), among others.